ERBB2 and neoplasm: Surprisingly, patients with luminal A tumors had a higher likelihood to present HER2+ DTCs compared with luminal B/HER2− and luminal B/HER2+ subtypes, hence suggesting the occurrence of discordance between DTCs and the primary tumor profile.